Neurocrine Biosciences Announces CEO Succession Plan marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the twenty-three analysts that are covering the firm, Marketbeat reports. Six analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. The average twelve-month target price among […]
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) – Investment analysts at William Blair dropped their Q1 2024 EPS estimates for Neurocrine Biosciences in a report released on Wednesday, February 7th. William Blair analyst M. Minter now expects that the company will earn $1.04 per share for the quarter, down from their prior estimate of $1.19. […]
Swiss National Bank cut its stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 10.9% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 313,800 shares of the company’s stock after selling 38,400 shares during the period. Swiss National Bank […]
Neurocrine Biosciences, Inc (NASDAQ:NBIX) Forecasted to Post Q4 2023 Earnings of $1 17 Per Share themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.